NCT07608055Recruiting
Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients
Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss Following Partial, Near-Total, and Total Pancreatectomy in Patients Without Diabetes at Baseline: A Monocentric Ambispective Observational Study
Source: ClinicalTrials.gov · Last updated 3 Sept 2026
Brief summary (registry, in English)
This study will examine how removal of part or all of the pancreas affects blood sugar control, metabolism, and clinical outcomes over time. The study will include adults without diabetes before surgery who undergo pancreatic surgery as part of routine clinical care at Fondazione Policlinico Universitario A. Gemelli IRCCS. Researchers will study whether participants develop diabetes after surgery and whether this risk changes according to the type of pancreatic resection. Information from routine clinical care, metabolic tests, imaging, and pancreatic tissue samples collected during surgery may be used for research analyses.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 579 (estimated)
- First submitted
- 21 May 2026
- Start date
- 20 Jul 2026
- Primary completion date
- May 2037
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- Pancreatic cancer, Type 2 diabetes
- NCT number
- NCT07608055
What you commit to
- Study type: Observational
- Planned participants: 579
- From 20 Jul 2026 to the primary completion date, May 2037
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diabetes mellitus at baseline
Age
- Age \<18 years
Other
- Missing key clinical data precluding eligibility assessment or primary outcome evaluation
- Refusal or inability to provide informed consent for the prospective component, where applicable
Who the study is looking for
- Adult patients (≥18 years)
- No diabetes mellitus at baseline
- Undergoing partial, near-total, or total pancreatectomy at the study center
- Availability of clinical and metabolic data according to study component
- Written informed consent for the prospective component
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS Coordinator of this site? Confirm its status | Rome | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.